Should You Buy Injective in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been closely monitoring the performance of the Injective cryptocurrency for over three years. Every month, hundreds of thousands of users across Australia trust us to analyse market trends and identify the best investment opportunities. Please note that our analyses are provided for informational purposes only and do not constitute investment advice. In line with our ethical policy, HelloSafe has never purchased Injective nor received compensation from any entities associated with its ecosystem.

Injective in brief

How much does one Injective cost?

The price of Injective is rising this week. Currently, INJ is trading at approximately $19.70 AUD, showing a solid increase of +7.5% over the past 24 hours and up +7% over the last week.

Injective's market cap stands around $1.94 billion AUD, with an average daily trading volume of about $138 million AUD in the past three months, putting it at rank #49 by market capitalisation.

The circulating supply is close to 99.9 million INJ, representing roughly 0.11% of the total crypto market.

As with all digital assets, INJ's price can be highly volatile, making it a dynamic option for proactive investors in Australia.

Our complete opinion on the Injective crypto

Have Injective’s recent market dynamics positioned it for a new growth phase within the DeFi sector? After examining Injective’s evolution over the past three years—leveraging on-chain metrics, technical signals, market data, and competitive insights processed via our proprietary algorithms—the patterns are compelling. So, why could Injective prove to be a strategic entry point for investors seeking exposure to the next cycle of innovation and value creation in decentralised finance in 2025?

Recent Performance and Market Context

Price Evolution

Over the last 12–18 months, Injective (INJ) has demonstrated significant outperformance relative to broader crypto indices, with a remarkable +170% increase year-on-year. Trading volumes have recently averaged $90–95 million USD daily, reflecting a sustained uptick in liquidity and active market participation. Since the start of Q2 2025, INJ’s price has consolidated in the $12–14 range, showing resilience and forming a robust base following last year’s rapid rally.

Positive Recent Events

• Injective EVM Launch (Jan 2025): A transformative update enabling full Ethereum smart contract compatibility, which has opened Injective to the floodgates of EVM liquidity, dApps, and developer activity.
• Ecosystem Growth: The protocol surpassed 2 billion trustless transactions executed without interruption, testifying to its technical robustness and high throughput.
• High Profile Partnerships: Active integrations with DeFi platforms and cross-chain collaborations continue to expand its reach and network effects.

Macro and Sector Tailwinds

The macro landscape remains supportive for digital assets, with renewed institutional attention on programmable blockchains, surging global DeFi adoption, and regulatory frameworks in Australia trending towards legitimising cryptofinance. These factors create a favourable tailwind for Layer-1 protocols, especially those like Injective that bridge CeFi and DeFi through highly composable infrastructure.

Technical Analysis

Key On-Chain and Market Indicators

• Relative Strength Index (RSI): Currently hovering between 57–60 based on daily charts—a neutral to bullish zone, signalling potential for upward momentum without overbought risk.
• MACD: Recent bullish crossover, with fast-moving averages above signal lines, indicating resurgent buying pressure.
• Moving Averages: The 50-day EMA sits above the 200-day EMA, confirming a medium-term uptrend.
• Support and Resistance Levels: Immediate support at $11.30 has repeatedly held during pullbacks, with $14.16 identified as a critical resistance. A decisive move above this threshold could unlock further upside.

Short–Medium Term Structure

• Consolidation Pattern: INJ has traced a series of higher lows, with volatility compression often preceding a breakout.
• Volume Trends: Persistent high volume on up-days signals accumulation, while the current volatility landscape remains conducive to dynamic upside moves.

Overall, the technical setup suggests that Injective is exhibiting healthy consolidation above major support, with the necessary catalysts in place for potential breakout acceleration.

Fundamental Analysis

Expanding Adoption and Strategic Drivers

• Ecosystem Expansion: Launch of EVM compatibility dramatically increases developer onboarding and accelerates the roll-out of new DeFi and Web3 apps.
• Staking and Tokenomics: 56–58% of INJ is staked, locking supply and offering a 10.68% yield—strengthening long-term holder conviction.
• Token Burn Mechanism: Over 7 million INJ have been burned to date; 60% of protocol fees are continually destroyed biweekly, creating structural scarcity.

Relative Valuation and Market Position

• Market Cap: At $1.26–1.29 billion USD, INJ remains attractively valued compared to similarly scaled Layer-1 competitors with less innovative features or weaker on-chain traction.
• Fully Diluted Value (FDV): Minimal dilution risk as the total token supply is capped at 100 million INJ, with nearly all tokens already circulating.
• TVL Strength: With $21.5 million locked, TVL is rising in tandem with dApp launches and liquidity mining incentives.

Structural Advantages

• Technological Differentiation: Optimised Layer-1 design for high-speed, decentralised derivatives trading with zero gas fees for takers and seamless cross-chain interoperability.
• Community and Developer Activity: A vibrant, expanding ecosystem of developers and dApp teams drives sustained on-chain activity.
• Network Effects: Each strategic partnership (notably in the Asia-Pacific and Australia) enhances the protocol’s network utility and user stickiness.

Volume and Liquidity

• High Trading Volume: Daily turnover consistently near $90 million USD, demonstrating both depth and confidence among active crypto investors.
• Top Cap Dominance: INJ sits comfortably within the upper tier of DeFi/L1 assets by market capitalisation, which increases visibility and inclusion in institutional portfolios and crypto indices.

Positive Catalysts Ahead

• Ecosystem funds worth $150 million accelerating project grants and user incentives.
• Expanded regulatory clarity in AU and other global markets supportive of institutional capital flows.
• Upcoming integrations with NFT and real-world asset tokenisation (RWA), opening new use cases and adoption avenues.
• Continuous protocol upgrades and EVM enhancements scheduled through 2025 and beyond.

Investment Strategies (by Time Horizon)

Short-Term (Weeks–Few Months)

• Swing Entries on Pullbacks: Current price consolidation offers a well-defined entry zone near major support, with the upside triggered by anticipated protocol upgrades or EVM-based dApp launches.
• Event-Driven Plays: Positioning ahead of scheduled protocol upgrades or EVM ecosystem announcements could yield dynamic price appreciation.

Medium-Term (6–18 Months)

• Staking for Yield: Locking tokens for 10–11% APY, benefiting from fee revenue and structural scarcity via burn events.
• Adoption Growth: Capturing value from accelerating institutional and developer adoption as Real-World Asset (RWA), DeFi, and cross-chain narratives gain traction.

Long-Term (2–5 Years)

• Secular Layer-1 DeFi Bet: Exposure to a protocol at the intersection of DeFi, cross-chain interoperability, and scalable dApp infrastructure, with robust tokenomics and a capped supply.
• Proactive Portfolio Positioning: Early alignment with one of the most innovative DeFi Layer-1 platforms as institutional allocations to crypto expand in Australia and the region.

INJ Price Predictions (2025–2029)

Is Now the Right Time to Consider Injective?

Both the macro and micro outlook for Injective present a case of rejuvenated momentum and long-term upside. Key positives include:

• Compelling post-EVM integration growth: Opens Injective to the largest liquidity pools and smart contract developer base in the world.
• Structural scarcity and sustainable yield: Token burns and above-market staking returns reduce supply while rewarding holders.
• Deepening ecosystem and developer activity: Major upgrades and expanding use cases in DeFi, NFTs, and tokenised assets support sustained network expansion.
• High institutional and retail interest: Evidenced by surging trading volumes, top-tier capitalisation, and favourable regulatory signals.

With strong technical structure, a differentiated product suite, and multiple high-potential catalysts on the horizon, Injective could well be entering a new bullish phase. For investors seeking dynamic, high-conviction opportunities in next-generation decentralised finance, Injective’s current price zone appears to offer a compelling entry—backed by solid fundamentals, an aligned community, and powerful upcoming milestones.

Important Investment Notice

Injective remains a high-volatility crypto asset offering prime opportunities for dynamic investment, requiring disciplined risk management. Its recent price acceleration highlights Injective’s capacity for rapid, outsized moves, though macroeconomic shifts call for selectivity. Structural supports near $11.30 and resistance at $14.16 are the main levels to watch, and the next major protocol upgrade in Q2 2025 may well act as a decisive catalyst for Injective’s next market cycle.

How to buy Injective?

It is straightforward and secure for Australians to buy Injective (INJ) online through a regulated crypto platform. There are two main ways to get exposure: spot buying (which gives you real ownership of INJ tokens) and trading via crypto CFDs (which allows you to speculate on price movements without holding actual coins). Each approach has its pros, cons, and fee structures. To make the right choice for your goals, it’s important to understand how both methods work. For a detailed comparison of recommended platforms in Australia, see the comparison table further down the page.

Spot Purchase

Buying Injective on the spot market means you actually own INJ tokens, which are stored in your crypto wallet. This is the most direct way to gain exposure and benefit from price increases. Fees typically include a fixed trading commission per transaction, often between 0.1% and 1%, plus a flat fee for AUD deposits (around $0–$5 depending on the platform).

Example

Example: Suppose Injective is trading at $19.60 AUD per coin (approximate rate for $12.90 USD). With an investment of $1,000 AUD, you can buy about 51 INJ tokens ($1,000 ÷ $19.60), accounting for roughly $5 AUD in fees.
- Profit scenario: If Injective’s price rises by 10% (from $19.60 to $21.56 per coin), your holding is now worth approximately $1,100 AUD.
- Result: That’s a $100 gain, or +10% on your initial investment (excluding any withdrawal fees).

Trading via CFD

Trading Injective with CFDs means you do not own the actual underlying token; rather, you speculate on its price movements, often using leverage. This can increase gains—but also risks. With CFDs, you’ll pay a spread (the difference between buy/sell price), and if you hold your position overnight, there is typically an overnight financing fee.

Example

Example: You open a CFD position on INJ with $1,000 AUD and use 5:1 leverage, giving you exposure to $5,000 AUD worth of INJ.
- Profit scenario: If INJ rises by 8%, your position gains 8% × 5 = 40%.
- Result: This means a gain of $400 AUD on your $1,000 stake (before fees such as spread and overnight charges).

Final Guidance

Before investing, always compare the fees, spreads, deposit/withdrawal conditions, and trading tools available on each platform. The best choice depends on your objectives and comfort with risk: spot buying suits long-term investors seeking real ownership, while CFDs may appeal to more experienced traders comfortable with leverage. Consult our in-depth platform comparison below to help you make a well-informed decision.

Our 7 tips for buying Injective

The latest news about Injective

Injective posted a strong weekly price gain of 7%, driven by heightened global trading activity. INJ traded in a positive trajectory this past week, with daily volume oscillating around $90–95 million USD and the token price up about 7% from the previous seven days. This surge is reflective of renewed institutional and retail interest, supported by technical signals indicating consolidation above key support levels. For the Australian market, such positive momentum has translated into increased activity across local crypto exchanges, notably Swyftx and CoinSpot, which both reported higher INJ transaction volumes and liquidity, facilitating easier access for AU-based investors and traders.

Recent implementation of Injective EVM integration is beginning to unlock broader DeFi opportunities for Australian builders and users. The January rollout of Injective’s Ethereum Virtual Machine (EVM) compatibility has started to bear fruit, with new interoperability features enabling Australian developers to deploy or port Ethereum-based decentralized applications (dApps) on Injective’s high-performance Layer-1 network. This is fostering local innovation in decentralized trading and derivatives, an area of growing demand in Australia’s rapidly evolving fintech ecosystem, and sets the stage for increased institutional participation in DeFi products built on Injective.

Injective’s staking yield remains robust at 10.68%, with nearly 58% of supply staked—a positive signal for AU passive income seekers. Over the past week, the protocol’s staking mechanism continued to offer a highly competitive 10.68% yield, attracting both individual and institutional stakers from Australia. With more than half of all INJ in circulation staked, and a capped total supply of 100 million tokens, this fosters a positive narrative around scarcity, security, and network decentralization—all factors that appeal to the growing number of Australian crypto-asset managers exploring long-term yield opportunities and portfolio diversification via regulated domestic platforms.

Ongoing ecosystem initiatives, including the $150 million developer fund, are fueling fresh strategic partnerships and community-led DeFi projects. In the past week, ecosystem funding initiatives—including the marquee $150M developer and liquidity fund—have been spotlighted on Australian crypto news outlets and industry events, signalling growing cross-continental collaboration. This momentum is drawing AU Web3 startups, independent dApp teams, and institutional partners to explore grant opportunities, technology sharing, and new market entries, positioning Injective as a key DeFi infrastructure layer for Oceania in 2025.

Australia maintains an increasingly receptive regulatory stance toward DeFi tokens like INJ, supporting local market integration. Recent communications by the Australian Securities and Investments Commission (ASIC) and Treasury reinforce a pragmatic, innovation-driven approach to digital asset regulations. Combined with the tax guidance available for staking and capital gains, this climate is supporting wider acceptance of INJ among Australian investors, exchanges, and regulated financial products, solidifying Injective’s long-term prospects in the AU crypto environment.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.